Intractable epilepsy: management and therapeutic alternatives.
More than half of patients with newly diagnosed epilepsy achieve complete seizure control without major side-effects. Patients who continue to have seizures after initial medical therapy should have an early and detailed assessment to confirm the diagnosis, to determine the underlying cause and epilepsy syndrome, and to choose an adequate treatment strategy. The risks and potential benefits of surgical procedures or experimental therapy have to be weighed against the chance of improvement and the potential side-effects of additional medical therapy. Surgery for temporal lobe epilepsy, the most common cause of focal epilepsy, can control seizures and improve quality of life in appropriately selected patients. However, around 20-30% of patients do not respond to medical or surgical treatment. The management of chronic intractable epilepsy requires comprehensive care to address the adverse events of medical treatment, quality of life issues, and comorbid disorders. Much research focuses on the experimental treatment options that offer hope of seizure reduction or cure.
Schuele
Stephan U
SU
Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA. s-schuele@northwestern.edu
Lüders
Hans O
HO
D000927:Anticonvulsants / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology / Q000601:surgery*; D002908:Chronic Disease / Q000628:therapy; D015897:Comorbidity; D004599:Electric Stimulation Therapy / Q000706:statistics & numerical data / Q000639:trends; D004569:Electroencephalography / Q000592:standards; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D019635:Neurosurgical Procedures / Q000379:methods / Q000706:statistics & numerical data*; D011788:Quality of Life; D018570:Risk Assessment; D016896:Treatment Outcome
D000927:Anticonvulsants